By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OpGen, Inc. 

505 South Rosa Road
Suite 151
Madison  Wisconsin  53719  U.S.A.
Phone: 608-441-8100 Fax:




Company News
OpGen (OPGN) To Present Data Showing Acuitas Tests Are Effective Tools For Investigating Transmission Of "Super Bugs" 9/22/2015 7:59:08 AM
OpGen (OPGN) Reports Second Quarter Financial Results And Provides Business Update 8/14/2015 10:44:35 AM
OpGen (OPGN) Announces Timing For Second Quarter Financial Results And Conference Call 8/5/2015 10:18:24 AM
OpGen (OPGN) Closes $6 Million Financing With Merck GHI To Expand Infectious Disease Diagnostic Testing Capabilities 7/14/2015 7:27:16 AM
Fluidigm Corporation And OpGen (OPGN) Enter Into Strategic Agreement To Develop Multi-Drug Resistance Testing Kits And Equipment 7/13/2015 10:12:07 AM
OpGen (OPGN) Reports First Quarter Financial Results And Provides Business Update 6/18/2015 7:31:46 AM
OpGen (OPGN) Releases Next-Generation Molecular Testing And Bioinformatics Solution For Combating Multi-Drug Resistant Infections 6/2/2015 10:54:04 AM
OpGen (OPGN)'s Acuitas MDRO Gene Tests And Bioinformatics Data To Be Presented At ASM2015 5/27/2015 8:15:48 AM
OpGen Announces Pricing Of IPO 5/5/2015 8:20:35 AM
OpGen's Acuitas MDRO Gene Test Data Presented At 25th European Congress Of Clinical Microbiology And Infectious Diseases 4/29/2015 12:37:59 PM